Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection

Immunity

Volumn 12, Issue 1, 2000, Pages 61-70

  Kanazawa, Satoshi ^a   Okamoto, Takashi ^b   Peterlin, B Matija ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; ELONGATION FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RNA; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BARE LYMPHOCYTE SYNDROME; BINDING COMPETITION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TRANSCRIPTION REGULATION;

EID: 0033978121     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80159-4     Document Type: Article

References (62)

1. Auwerx, J. (1991). The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47, 22-31.
2. Barre-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzious, C., et al. (1983). Isolation of a T-lymphocyte retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871.
3. Bieniasz, P.D., Grdina, T.A., Bogerd, H.P., and Cullen, B.R. (1998). Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17, 7056-7065.
4. Bieniasz, P.D., Grdina, T.A., Bogerd, H.P., and Cullen, B.R. (1999). Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc. Natl. Acad. Sci. USA 96, 7791-7796.
5. Brown, J.A., Howcroft, T.K., and Singer, D.S. (1998). HIV Tat protein requirements for transactivation and repression of transcription are separable. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17, 9-16.
6. Calman, A.F., and Peterlin, B.M. (1988). Evidence for a trans-acting factor that regulates the transcription of class II major histocompatibility complex genes: genetic and functional analysis. Proc. Natl. Acad. Sci. USA 85, 8830-8834.
7. Chang, C.H., Fontes, J.D., Peterlin, M., and Flavell, R.A. (1994). Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180, 1367-1374.
8. Chen, D., Fong, Y., and Zhou, Q. (1999). Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc. Natl. Acad. Sci. USA 96, 2728-2733.
9. Douhan, J., 3rd, Hauber, I., Eibl, M.M., and Glimcher, L.H. (1996). Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D α and β chains. J. Exp. Med. 183, 1063-1069.
10. Ennen, J., Seipp, I., Norley, S.G., and Kurth, R. (1990). Decreased accessory cell function of macrophages after infection with human immunodeficiency virus type 1 in vitro. Eur. J. Immunol. 20, 2451-2456.
11. Fiering, S., Northrop, J.P., Nolan, G.P., Mattila, P.S., Crabtree, G.R., and Herzenberg, L.A. (1990). Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. Genes Dev. 4, 1823-1834.
12. Fontes, J.D., Jabrane-Ferrat, N., Toth, C.R., and Peterlin, B.M. (1996). Binding and cooperative interactions between two B cell-specific transcriptional coactivators. J. Exp. Med. 183, 2517-2521.
13. Fontes, J.D., Jiang, B., and Peterlin, B.M. (1997). The class II transactivator CIITA interacts with the TBP-associated factor TAFII32. Nucleic Acids Res. 25, 2522-2528.
14. Fontes, J.D., Kanazawa, S., Jean, D., and Peterlin, B.M. (1999). Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol. Cell. Biol. 19, 941-947.
15. Fujinaga, K., Cujec, T.P., Peng, J., Garriga, J., Price, D.H., Grana, X., and Peterlin, B.M. (1998). The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J. Virol. 72, 7154-7159.
16. Fujinaga, K., Taube, R., Wimmer, J., Cujec, T.P., and Peterlin, B.M. (1999). Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. USA 96, 1285-1290.
17. Garber, M.E., Wei, P., KewalRamani, V.N., Mayall, T.P., Herrmann, C. H., Rice, A.P., Littman, D.R., and Jones, K.A. (1998). The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12, 3512-3527.
18. Gelderblom, H., Reupke, H., Winkel, T., Kunze, R., and Pauli, G. (1987). MHC-antigens: constituents of the envelopes of human and simian immunodeficiency viruses. Z. Naturforsch. 42, 1328-1334.
19. Gold, M.O., and Rice, A.P. (1998). Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression. Nucleic Acids Res. 26, 3784-3788.
20. Greenberg, M.E., Iafrate, A.J., and Skowronski, J. (1998). The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 17, 2777-2789.
21. Herman, A., Kappler, J.W., Marrack, P., and Pullen, A.M. (1991). Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9, 745-772.
22. Hockett, R.D., Kilby, J.M., Derdeyn, C.A., Saag, M.S., Sillers, M., Squires, K., Chiz, S., Nowak, M.A., Shaw, G.M., and Bucy, R.P. (1999). Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J. Exp. Med. 189, 1545-1554.
23. Howcroft, T.K., Strebel, K., Martin, M.A., and Singer, D.S. (1993). Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260, 1320-1322.
24. Ivanov, D., Kwak, Y.T., Nee, E., Guo, J., Garcia-Martinez, L.F., and Gaynor, R.B. (1999). Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation. J. Mol. Biol. 288, 41-56.
25. Jones, K.A., and Peterlin, B.M. (1994). Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63, 717-743.
26. Knight, S.C., Macatonia, S.E., and Patterson, S. (1990). HIV I infection of dendritic cells. Int. Rev. Immunol. 6, 163-175.
27. Kretsovali, A., Agalioti, T., Spilianakis, C., Tzortzakaki, E., Merika, M., and Papamatheakis, J. (1998). Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol. Cell. Biol. 18, 6777-6783.
28. Kwak, Y.T., Ivanov, D., Guo, J., Nee, E., and Gaynor, R.B. (1999). Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation. J. Mol. Biol. 288, 57-69.
29. Lanzavecchia, A., Reid, P.A., and Watts, C. (1992). Irreversible association of peptides with class II MHC molecules in living cells. Nature 357, 249-252.
30. Le Gall, S., Erdtmann, L., Benichou, S., Berlioz-Torrent, C., Liu, L., Benarous, R., Heard, J.M., and Schwartz, O. (1998). Nef interacts with the μ subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8, 483-495.
31. Li, Y., Knappes, J.C., Conway, J.A., Price, R.W., Shaw, G.M., and Hahn, B.H. (1991). Molecularcharacterizationof human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J. Virol. 65, 3973-3985.
32. Locati, M., and Murphy, P.M. (1999). Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med. 50, 425-440.
33. Macatonia, S.E., Gompels, M., Pinching, A.J., Patterson, S., and Knight, S.C. (1992). Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection. Immunology 75, 576-581.
34. Mach, B., Steimle, V., Martinez-Soria, E., and Reith, W. (1996). Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14, 301-331.
35. Mahanta, S.K., Scholl, T., Yang, F.C., and Strominger, J.L. (1997). Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. USA 94, 6324-6329.
36. Mancebo, H.S., Lee, G., Flygare, J., Tomassini, J., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D., Price, D., and Flores, O. (1997). P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11, 2633-2644.
37. Masternak, K., Barras, E., Zufferey, M., Conrad, B., Corthals, G., Aebersold, R., Sanchez, J.C., Hochstrasser, D.F., Mach, B., and Reith, W. (1998). A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20, 273-277.
38. McMichael, A. (1998). T cell responses and viral escape. Cell 93, 673-676.
39. Meltzer, M.S., and Gendelman, H.E. (1992). Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease. Curr. Top. Microbiol. Immunol. 181, 239-263.
40. Miedema, F. (1992). Immunological abnormalities in the natural history of HIV infection: mechanisms and clinical relevance. Immunodefic. Rev. 3, 173-193.
41. Miller, D.M., Rahill, B.M., Boss, J.M., Lairmore, M.D., Durbin, J.E., Waldman, J.W., and Sedmak, D.D. (1998). Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187, 675-683.
42. Muhlethaler-Mottet, A., Otten, L.A., Steimle, V., and Mach, B. (1997). Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16, 2851-2860.
43. Muhlethaler-Mottet, A., Di Berardino, W., Otten, L.A., and Mach, B. (1998). Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1. Immunity 8, 157-166.
44. Nagarajan, U.M., Louis-Plence, P., DeSandro, A., Nilsen, R., Bushey, A., and Boss, J.M. (1999). RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10, 153-162.
45. Nelson, C.A., Petzold, S.J., and Unanue, E.R. (1994). Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371, 250-252.
46. Peng, J., Zhu, Y., Milton, J.T., and Price, D.H. (1998). Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12, 755-762.
47. Petit, A.J., Tersmette, M., Terpstra, F.G., de Goede, R.E., van Lier, R.A., and Miedema, F. (1988). Decreased accessory cell function by human monocytic cells after infection with HIV. J. Immunol. 140, 1485-1489.
48. Piskurich, J.F., Linhoff, M.W., Wang, Y., and Ting, J.P. (1999). Two distinct γ interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor β. Mol. Cell. Biol. 19, 431-440.
49. Polyak, S., Chen, H., Hirsch, D., George, I., Hershberg, R., and Sperber, K. (1997). Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection. J. Immunol. 159, 2177-2188.
50. Roilides, E., Mertins, S., Eddy, J., Walsh, T.J., Pizzo, P.A., and Rubin, M. (1990). Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor. J. Pediatr. 117, 531-540.
51. Rosenberg, E.S., LaRosa, L., Flynn, T., Robbins, G., and Walker, B.D. (1999). Characterization of HIV-1-specific T-helper cells in acute and chronic infection. Immunol. Lett. 66, 89-93.
52. Rowland-Jones, S.L., Dong, T., Dorrell, L., Ogg, G., Hansasuta, P., Krausa, P., Kimani, J., Sabally, S., Ariyoshi, K., Oyugi, J., et al. (1999). Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. Immunol. Lett. 66, 9-14.
53. Scholl, T., Mahanta, S.K., and Strominger, J.L. (1997). Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94, 6330-6334.
54. Sedmak, D.D., Guglielmo, A.M., Knight, D.A., Birmingham, D.J., Huang, E.H., and Waldman, W.J. (1994). Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am. J. Pathol. 144, 683-692.
55. Sheridan, P.L., Mayall, T.P., Verdin, E., and Jones, K.A. (1997). Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev. 11, 3327-3340.
56. Shilatifard, A. (1998). The RNA polymerase II general elongation complex. Biol. Chem. 379, 27-31.
57. Steimle, V., Otten, L.A., Zufferey, M., and Mach, B. (1993). Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75, 135-146.
58. Steimle, V., Siegrist, C.A., Mottet, A., Lisowska-Grospierre, B., and Mach, B. (1994). Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265, 106-109.
59. Tiley, L.S., Madore, S.J., Malim, M.H., and Cullen, B.R. (1992). The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes Dev. 6, 2077-2087.
60. Unanue, E.R. (1984). Antigen-presenting function of the macrophage. Annu. Rev. Immunol. 2, 395-428.
61. Wei, P., Garber, M.E., Fang, S.M., Fischer, W.H., and Jones, K.A. (1998). A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92, 451-462.
62. Wilson, I.A., Niman, H.L., Houghten, R.A., Cherenson, A.R., Connolly, M.L., and Lerner, R.A. (1984). The structure of an antigenic determinant in a protein. Cell 37, 767-778.